Watertown, Mass. (February 27, 2025) – Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying drivers of disease, today announced that its management team will host one-on-one meetings with investors at the Leerink Global Healthcare Conference on Monday, March 10, 2025 in Miami, FL. For […]